Zobrazeno 1 - 10
of 10
pro vyhledávání: '"E. E. Arinina"'
Autor:
N. S. Chipigina, N. Yu. Karpova, A. S. Vinokurov, E. E. Arinina, Yu. A. Ivanova, A. A. Gasparyan, P. A. Kashkovskaya, A. G. Makaev, M. S. Sapko
Publikováno v:
Архивъ внутренней медицины, Vol 13, Iss 4, Pp 272-281 (2023)
In contrast to trivial bacterial pneumonia, the diagnosis of septic pulmonary embolism poses a fundamental task for the doctor to search for primary sources of emboli, including right side infective endocarditis, and to change the tactics of managing
Externí odkaz:
https://doaj.org/article/1a5feb8bb5b74a318dfaf1bb667e6bdb
Autor:
A. N. Boyko, N. A. Shamalov, O. V. Boyko, E. E. Arinina, O. V. Lyang, E. A. Dubchenko, A. V. Ivanov, A. A. Kubatiev
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 12, Iss 3, Pp 82-86 (2020)
On March 11, 2020, the WHO announced the COVID-19 outbreak a pandemic. The disease was established to be caused by a new singlestranded RNA virus (ss-RNA, 29903 bp) that belongs to a group of coronaviruses (CoV).Objective: to assess the results of a
Externí odkaz:
https://doaj.org/article/5a0df1eb42384fb29df326e2ebdfaaad
Publikováno v:
Ведомости Научного центра экспертизы средств медицинского применения, Vol 0, Iss 4, Pp 58-63 (2018)
Ever since the first registrations of HIV-infections at the territory of the Russian Federation there was started a great process on arrangement and, subsequently, development of anti-HIV system. It should be noted, that increase of HIV screening and
Externí odkaz:
https://doaj.org/article/7c05ecc0602b4f2f91980cd750c22631
Autor:
N. G. Goloenko, R. I. Yagudina, B. K. Romanov, R. N. Alyautdin, D. G. Karapetyan, E. G. Zelenova, E. E. Arinina, A. Yu. Kulikov, M. V. Protsenko, G. T. Abdrashitova
Publikováno v:
Ведомости Научного центра экспертизы средств медицинского применения, Vol 7, Iss 1, Pp 59-63 (2018)
The article summarises the results of a 2015 survey of healthcare professionals and pharmacists that was aimed to reveal their educational needs on the subject of interchangeable medicines. It was discovered that the respondents were not sufficiently
Externí odkaz:
https://doaj.org/article/b7be9f90f336463ea6a8ea9a595f942b
Autor:
E. E. Arinina, M. A. Rashyd
Publikováno v:
Фармакоэкономика, Vol 5, Iss 3, Pp 41-46 (2015)
to conduct analysis of basal-bolus insulin detemir/aspart in comparison with the NPH/human insulin for the treatment of patients with diabetes mellitus type 1 in Russia. We evaluate results of PREDICTIVE study using pharmacoeconomic analyses: «cost
Externí odkaz:
https://doaj.org/article/348c35bcda3447d8936d8cedb230e491
Publikováno v:
Rossijskij Vestnik Perinatologii i Pediatrii, Vol 65, Iss 3, Pp 91-99 (2020)
Objective. To study the risk factors of noncommunicable disease spread in adolescents based on the mass pole results.Methods. The authors conducted four waves of study within the framework of the monitoring project “Risk factors for human health”
Autor:
E. A. Dubchenko, O. V. Boyko, A. A. Kubatiev, O. V. Lyang, A. V. Ivanov, E. E. Arinina, N A Shamalov, Aleksey Nikolaevich Boyko
Publikováno v:
Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 12, Iss 3, Pp 82-86 (2020)
On March 11, 2020, the WHO announced the COVID-19 outbreak a pandemic. The disease was established to be caused by a new singlestranded RNA virus (ss-RNA, 29903 bp) that belongs to a group of coronaviruses (CoV). Objective : to assess the results of
Publikováno v:
Научно-практическая ревматология, Vol 43, Iss 3 (2005)
Publikováno v:
Terapevticheskii arkhiv. 72(10)
Publikováno v:
Terapevticheskii arkhiv. 71(11)
To assess the response to nonsteroid antiinflammatory drug movalis in LBP syndrome.Movalis was given in daily dose 15 mg for 7 days, then 7.5 mg daily for 14 days to 22 patients with LBS aged 34-56 years. All the patients had lumbosacral intervertebr